• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Concord Drugs Ltd — Board Meeting, 10-08-2026: Board Meeting

    10-08-2026 | 05:31 pm

    Concord Drugs board approved Q1 results. Standalone revenue at Rs 20.89 Cr, net profit Rs 1.11 Cr. Consolidated revenue Rs 20.94 Cr, net profit Rs 1.11 Cr. EPS improved to Rs 0.85 (Cons.) despite equity dilution from a preferential issue. Strong earnings growth noted.

    No comments yet. Be the first to comment!

    All announcements from Concord Drugs Ltd